← Open Payments lookup

ASHLIE HEITZMAN: Open Payments

NPI 1336926153 · EPHRATA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$787 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $350 · 2025 $787

Food & beverage: $787
CompanyPaymentsAmount
ABBVIE INC.12$192
Janssen Biotech, Inc.4$97
Takeda Pharmaceuticals U.S.A., Inc.5$89
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$87
Celltrion USA Inc.2$75
Madrigal Pharmaceuticals3$71
Lilly USA, LLC2$46
PFIZER INC.2$29
Ardelyx, Inc.1$26
GENZYME CORPORATION1$23

Products named: RINVOQ, TREMFYA, XIFAXAN, REZDIFFRA, ENTYVIO, ZYMFENTRA, OMVOH, DUPIXENT.

Industry payments across PA — which companies pay providers there.